Serum antibodies against desmoglein 1 (Dsgl) are known to induce the clinical and histological manifestations of pemphigus foliaceus (PF), autoimmune bullous disease targeting skin. The basic pathophysiological phenomenon of PF blistering is the disruption of epithelial integrity in the granular layer of the epidermis due to separation of keratinocytes from one another, or acantholysis. In this report we investigate the changes in subcellular distribution of Dsgl in response to serum of patients with PF by using an in vitro model of PF. Immunofluorescence analysis on HaCaT cells indicates that non-clustered Dsgl is markedly internalized after exposure to serum. However, binding of PF IgG to Dsgl-rich adhesion complexes (desmosomes) does not cause disruption of such structures nor depletion of clustered Dsgl, as revealed by colocalization ofPF IgG and Dsgl in a punctate staining on cell membrane 24 hours after treatment. Furthermore, morphological studies demonstrate that the dramatic alterations induced by PF sera are not the result of apoptotic programs. Taken together, our data strongly suggest that anti-Dsgl antibodies from PF serum could cause the internalization of non-clustered Dsgl and perturb the formation of new desmosomes but not directly disrupt Dsgl-containing junctions when stable contacts are already formed.
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Pemphigus is a potentially fatal blistering disease of the skin and mucous membranes characterized by the loss of intercellular adhesion of keratinocytes, a process known as acantholysis (I). It is associated with the presence ofcirculating autoantibodies against antigens located on the surface of keratinocytes -or intercellular substance (lCS) (2) . There are two basic forms of pemphigus, vulgaris (PV) and foliaceus (PF), which affect different layers of the skin (3) . It is well established that in PF pathogenic autoantibodies react with desmoglein I (Dsg I) (4), desmosomal glycoprotein belonging to the cadherin superfamily of calcium-dependent cell adhesion molecules (5) (6) (7) (8) . Dsg l is the main skin-associated desmoglein, being expressed throughout the epidermis and most prominently in the differentiated layers. Indeed, anti-Dsg l antibodies are responsible for the high (subcomeal) acantholysis observed in histological specimen PF patients' skin (9) . Although intercellular antibodies have been shown to cause the clinical and histologic lesions of pemphigus, the exact mechanism by which they cause acantholysis still remains unclear. The binding ofthe autoantibody to its target would generate a plethora of biological effects due, on one hand, to their direct interference with adhesive function and, on the other, to more complex events involving intracellular pathways that modify protease activity or calcium metabolism, leading to loss of cell-cell adhesion (3, 10) .
Subcorneal acantholysis is a common finding of both PF and its localized form, pemphigus erythemathosus (PE); nevertheless, some aspects of PE immunopathology, including immune depositions along the basement membrane zone, differentiate this abortive variant from generalized PF (11-12). For this reason, and also to reproduce physiological conditions, cellular responses were triggered by using whole sera. As a prerequisite to investigate the pathophysiology of PF and the fate of Dsgl in our experimental cell system, we prepared HaCaT cells endogenously enriched in Dsgl. HaCaT cell line is accepted as a model for normal keratinocytes and is capable of forming differentiated epidermal tissue when transplanted in vivo (13) .
In this paper, we have studied the changes in cellular distribution of Dsg 1 in response to serum from PF through double-staining immunofluorescence microscopy. We also investigate the ability of such a serum to disrupt Dsg l-containing desmosomes, considered the primary event leading to acantholysis.
MATERIALS AND METHODS
Antibodies and sera H-290 rabbit antibodies against C-terminal residues 760-1046 of Dsgl, H-145 rabbit polyclonal antibodies raised against the cytoplasmic domain of Dsg3, the 5H I0 monoclonal antibody against an external region of Dsg3 and HRP-conjugated anti-rabbit antibodies were from Santa Cruz Biotecnology (Santa Cruz, CA). The H442 I IM mouse monoclonal antibody against the extracellular domain of Dsg I was from Biodesign International (Saco, MA). Texas red-and FITC-conjugated anti-mouse and anti-human IgG antibodies were from DAKO (Dako Denmark A/S).
Serum samples were collected from four patients with untreated PF and four healthy donors. Sera from PF patients were tested and found to have similar effects. The clinical diagnosis of PF was confirmed based on both histological and direct immunofluorescence (OIF) examinations. The presence of anti-Dsgl autoantibodies was determined by immunoprecipitation and Western blot, as detailed below. All sera were heated to 56°C for 30 min to inactivate complement (14) . Figures shown in the present paper were obtained using PF I serum.
Cell cultures and treatments
For our experiments, we used HaCaT cells, a nontumorigenic human keratinocyte cell line (13) . Cells from T-75 flasks were plated on 35 mm Petri dishes and maintained in Dulbecco's modified Eagle's medium (DMEM) in an atmosphere humidified with 5% CO 2 , After reaching confluence, cells were grown for an additional 7 days in KAD medium, consisting of a mixture (1: I) of keratinocytes growth medium (KGM) supplemented with growth factors and DMEM plus 10% FBS, with an overall calcium concentration ofabout 0.5 mM. KAD was supplemented with penicillin (50 Vlml), streptomycin (50 ,uglml) and fungizone (2.5 ,uglml). To block protein synthesis, cells were treated with 50,uglml CX.
Western blot analysis and immunoprecipitation
Triton X-I00 soluble membrane extracts were prepared as described for keratinocytes by Lanza and colleagues (15) .
Proteins subjected to immunoprecipitation were extracted by using the IP buffer (50 mM Tris-HCI, pH 7.5, 150 mM NaCI, 0,5% Nonidet P-40, 1 mM OTT, 1 mM PMSF). Combined immunoprecipitation-Western blotting was performed following the procedures reported in literature (15) (16) .
Immunofluorescence microscopy
Immunofluorescence studies were conducted as reported previously (17) . To study Dsgl internalization, cells were grown on glass coverslips and incubated in the presence or absence of normal or PF complementinactivated sera and CX. After washing with PBS, cells were fixed in paraformaldehyde solution (3% paraformaldehyde in PBS) for 20 min at room temperature; in some experiments, cells were permeabilized with 0.2% Triton X-100 in PBS. Samples were then washed three times in PBS containing 2% BSA to block nonspecific sites, incubated with the monoclonal primary antibody (I: 10) for I h at room temperature, washed in BSA/PBS, and exposed to species-specific antibodies (I: 100) conjugated to FITC or Texas red. In some experiments, cells were directly incubated with antihuman IgG to investigate deposits of serum antibodies in the intercellular space. Specimens were examined with a Zeiss Axiophot microscope (Calr Zeiss Inc., Thornwood, NY) at X 400 magnification, and fluorescence images were acquired with an Evolution VF fast digital camera (MediaCybernetics, UK).
Assessment ofapoptosis
Apoptosis was evaluated by nuclear stammg with Hoechst 33342 (5 ,ug/ml) on 3% formaldehyde-fixed cells, whereas detachment from substrate was estimated by counting adherent cells at different time points, as reported previously (19) . DNA extraction and the presence of DNA laddering were assessed following standard procedures (20) 
RESULTS

Characterization ofsera
Normal and PF sera were used for this study. Immunofluorescence on HaCaT keratinocytes showed that PF IgG, but not Nh IgG, described a fishnet-like pattern (Fig. lA, B) , indicating that in our experimental cell system PF IgG targeted antigen(s) located in the intercellular substance (ICS) of keratinocytes. Immunoreactivity of PF IgG was further identified by immunoprecipitation of HaCaT extracts. Western blot analysis of the immunocomplexes revealed that PF IgG recognized Dsgl but not Dsg3 (Fig. IC) .
PF serum trigger internalization ofDsgl
At the time of the experiments, cultured monolayers expressed Dsg3 and Dsgl, whereas Dsg2 was virtually absent (assessed by RT-PCR, not shown; and immunofluorescence, Fig. ID) . This in vitro pattern of expression resembles that observed in vivo in the stratum granulosum of epidermis (9) . Indeed, at the selected stage of differentiation, HaCaT cells cultured in KAD synthesized high levels of Dsgl and were useful for our purpose. Although it is accepted that IgG and complement-inactivated sera from pemphigus patients exert similar effects on keratinocytes (our personal observations and those from 17-18), we tested the ability ofwhole PF sera to induce acantholysis in our experimental conditions. Immunofluorescence performed on cultured HaCaT revealed that incubation with 30% PF serum induced specific changes in cell shape and formation of intercellular gaps ( Fig. 2A ). Keratinocytes exposed to serum showed a marked punctate staining of Dsgl diffused within cytoplasmic compartments 24 h after treatment. To test whether DsgI was depleted from the membrane fraction (including the new synthesized pool) in response to PF IgG, changes in Dsg I synthesis were investigated by evaluating the Triton X-IOO soluble pool of protein from cells exposed to PF serum. Western blot analysis did not show significant changes (reduction of about 5-10%) in this Triton-soluble pool of DsgI 24 h after exposure to serum ( Fig. 2A, WB) . It is unlikely that the dramatic morphological alterations observed were due to apoptotic changes, since no nuclear condensation of keratinocytes became evident within 48 h of treatment by using 30% (Fig. 2B ), 10% and 50% (v/v) PV sera (not shown). That cell death, in particular by apoptosis, did not take place in the above conditions was confirmed by the lack of both cell detachment from substrate and DNA laddering (not shown).
Taken together, these data demonstrate that Dsg1 is markedly internalized in response to PF serum.
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Fig. 2. (A) Changes in cell shape and marked internalization ofDsgl in response to PF serum at different time points. Immunofluorescence microscopy shows an intense intracellular Fl'I'Cfluorescence associated to Dsg1 24 h after expos ure to PF serum. Western blot analysis (WB) reveals that PF serum fail s to induce changes of Dsgl synthes is; hence, the marked cytoplasmic trafficking of Dsgl in response to PF serum is likely to be due to endocytic pathways and not to increased Dsg1 exocytosis toward cell surface. (B) Nuclei ofcultured keratinocytes exposed to PF serum appear similar to controls andfail to show condensation phenomena, typical ofapoptosis. Figures are representative ofthree independent experiments.
PFlgG DsgI Dsg3 Fig. 3 . Cells were incubated for 12 h with CX to block protein synth esis and then exposed to serum from PF patients f or additional 24 h. IgG-bound Dsgl appear internalized in cells exposed to PF 
serum, although the punctate staining on cell surface representing cell-cell contacts does not result markedly affec ted (A-D). Indeed. depletion ofmembrane Dsgl seems to include mainly the non-desmosomal areas. Subcellular distribution ofDsg3 results unchanged (E-F). Figures are representative ofthree independent experiments.
Effect of PF autoantibodies binding on desmosome-like clusters ofDsgJ
To address whether PF serum is able to dismantle Dsg I-containing adhesion complexes (desmosomes) or deplete Dsg I from such structures, we stopped protein synthesis by pre-treating cells with CX to prevent formation of new desmosomes and then incubated cells with PF serum. Desmosomes were identified as areas of punctate staining between adjacent cells, constituted by spots of aggregated clusters of Dsg I. FITC fluorescence was distributed also in the non-desmosomal areas as a linear pattern over the entire cell surface, referred to as simple clusters of Dsg I. Immunofluorescence analysis showed PF-lgG at sites of cell-cell contact 24 h after treatment (Fig. 3A, C) . PF IgG co-localized with Dsg I, suggesting that Dsg I was still present in desmosomes. However, after exposure to PF serum, Dsg I staining along non-desmosomal areas was reduced (Fig. 3B, D) . In the same conditions, Dsg3 labelling was not affected by exposure to anti-Dsg l IgG (Fig.3 C, F) , providing strong evidence that redistribution of fluorescence was a Dsg l-specific phenomenon. Furthermore, the marked intracellular fluorescence confirmed that the observed cytoplasmic trafficking of Dsg I in response to PF serum did not represent exocytic pathways of newly synthesized Dsg l , since protein synthesis had been blocked by CX. Taken together, these findings suggest that PF autoantibodies are not able to directly disrupt Dsg 1containing adhesion complexes nor cause depletion of Dsg I from desmosomes when stable contacts are made, but they just trigger internalization of unassembled, non-clustered, Dsg I.
DISCUSSION
The understanding ofpemphigus pathophysiology must take into consideration the fate of desmogleins. Data reported here support the idea that anti-Dsg I antibodies found in PF serum induce the internalization of free, non-clustered pool of Dsg I from cell surface, whereas they are not able to cause disruption of punctate aggregates of Dsg I referring to desmosomes, as revealed by double-staining immunofluorescence microscopy.
To investigate the fate of Dsg I in our cell system, we induced a sustained expression of such a protein by using KAD medium and left HaCaT keratinocytes to differentiate for 7 days. Cells were then treated with serum from patients with PF and the distribution of Dsg I, Dsg3 and PF IgG was revealed by Texas Red and FITC fluorescence. The intense punctate staining referring to membrane aggregated clusters of Dsg l represented desmosomal structures, whereas Dsg I labelled in a linear pattern was considered as non-desmosomal Dsg I. The intracellular trafficking of Dsg I was visualized in penneabilized cells by cytoplasmic punctuate staining. To exclude that the intense intracellular staining observed by immunofluorescence microscopy was the result of a sustained exocytic pathway due to an increased rate of Dsg I synthesis, we stopped protein synthesis through CX. Furthermore, Western blot analysis of the Triton-soluble pool of protein, representing mainly the newly synthesized fraction (14), did not show increases in the levels of Dsg I 24 h after exposure to serum. Hence, we assumed that PF serum actually induced internalization of Dsg I.
Since apoptosis and acantholysis could be related phenomena (21) , we tested whether this presumed endocytic-recycling pathway took place as a result of the apoptotic machinery eventually triggered by PF serum. Lack of nuclear condensation, DNA laddering and detachment from substrate, hallmarks of programmed cell death, demonstrated that internalization of Dsg I in PF was not the result of apoptotic programs.
On the basis of our findings we conclude that, in the above experimental conditions, the cellular response to PF serum includes internalization of PF IgG-bound non-clustered Dsg I present on cell surface. Vice versa, Dsg l-containing desmosomelike spots apparently maintain their structural integrity, although PF IgG also bind these clustered Dsg I; it is likely that PF IgG are not able to induce internalization of desmosomal Dsg l , since PF IgG and Dsg I still co-localized in a surface punctate staining 24 h after treatment. We favour the hypothesis that non-clustered Dsg I represents the soluble, not yet assembled, form ofcell surface Dsg I, whereas clustered Dsg I is likely to be included into the junctional complex. Indeed, Dsg I could become insoluble after its arrival on plasma membrane, where the protein is transported in soluble fonn (N. Cirillo, A. Lanza, unpublished data).
Although PF phenomenology has been subjected to extensive studies, at present there are no works exploring the subcellular fate of Dsg l in an in vitro model of PF. Previous investigations have in part revealed the complex phenomena underlying the induction of acantholysis by the anti-Dsg l antibodies (22) . However, convincing evidence probing the involvement of mechanisms other than steric hindrance in the pathogenesis of acantholysis is still lacking (23) . Our results are compatible with the idea of a direct interference with the adhesion function of DsgI, in that anti-DsgI antibodies could perturb the formation of new desmosomes even though they do not cause disruption of those already formed.
In conclusion, our data show for the first time the basic changes in the subcellular localization ofDsgl in PF and provide further insight into the mechanisms underlying epithelial blistering observed in the skin type of pemphigus.
